GRI
Price
$1.26
Change
-$0.02 (-1.56%)
Updated
Jun 27, 12:55 PM (EDT)
Capitalization
3M
OCS
Price
$19.48
Change
-$0.00 (-0.00%)
Updated
Jun 27, 12:10 PM (EDT)
Capitalization
994.14M
Interact to see
Advertisement

GRI vs OCS

Header iconGRI vs OCS Comparison
Open Charts GRI vs OCSBanner chart's image
GRI Bio
Price$1.26
Change-$0.02 (-1.56%)
Volume$200
Capitalization3M
Oculis Holding AG
Price$19.48
Change-$0.00 (-0.00%)
Volume$100
Capitalization994.14M
GRI vs OCS Comparison Chart in %
Loading...
GRI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OCS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GRI vs. OCS commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GRI is a Hold and OCS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (GRI: $1.28 vs. OCS: $19.48)
Brand notoriety: GRI and OCS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GRI: 74% vs. OCS: 52%
Market capitalization -- GRI: $3M vs. OCS: $994.14M
GRI [@Biotechnology] is valued at $3M. OCS’s [@Biotechnology] market capitalization is $994.14M. The market cap for tickers in the [@Biotechnology] industry ranges from $113.86B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GRI’s FA Score shows that 2 FA rating(s) are green whileOCS’s FA Score has 0 green FA rating(s).

  • GRI’s FA Score: 2 green, 3 red.
  • OCS’s FA Score: 0 green, 5 red.
According to our system of comparison, GRI is a better buy in the long-term than OCS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GRI’s TA Score shows that 2 TA indicator(s) are bullish while OCS’s TA Score has 4 bullish TA indicator(s).

  • GRI’s TA Score: 2 bullish, 4 bearish.
  • OCS’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, OCS is a better buy in the short-term than GRI.

Price Growth

GRI (@Biotechnology) experienced а -8.57% price change this week, while OCS (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.92%. For the same industry, the average monthly price growth was +39.30%, and the average quarterly price growth was +17.54%.

Reported Earning Dates

GRI is expected to report earnings on May 15, 2025.

OCS is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (+9.92% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OCS($994M) has a higher market cap than GRI($3.01M). OCS has higher P/E ratio than GRI: OCS (63.08) vs GRI (0.03). OCS YTD gains are higher at: 14.588 vs. GRI (-90.911). GRI has higher annual earnings (EBITDA): -9.39M vs. OCS (-101.78M). OCS has more cash in the bank: 182M vs. GRI (3.28M). GRI has less debt than OCS: GRI (108K) vs OCS (1.1M). GRI (0) and OCS (0) have equivalent revenues.
GRIOCSGRI / OCS
Capitalization3.01M994M0%
EBITDA-9.39M-101.78M9%
Gain YTD-90.91114.588-623%
P/E Ratio0.0363.080%
Revenue00-
Total Cash3.28M182M2%
Total Debt108K1.1M10%
FUNDAMENTALS RATINGS
GRI: Fundamental Ratings
GRI
OUTLOOK RATING
1..100
2
VALUATION
overvalued / fair valued / undervalued
1..100
1
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
66
P/E GROWTH RATING
1..100
3
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GRIOCS
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
40%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
34%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
40%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
51%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
56%
Advances
ODDS (%)
Bullish Trend 10 days ago
88%
Bullish Trend 4 days ago
73%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 8 days ago
63%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
36%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
51%
View a ticker or compare two or three
Interact to see
Advertisement
GRI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OCS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DOMYX10.320.11
+1.08%
Domini Impact International Equity Y
RIGBX42.280.42
+1.00%
American Funds Intl Gr and Inc R2
DFETX20.48N/A
N/A
DFA Emerging Markets II
HSLCX38.52N/A
N/A
Hartford Small Cap Growth C
SHTCX40.94N/A
N/A
Columbia Seligman Global Tech C

GRI and

Correlation & Price change

A.I.dvisor indicates that over the last year, GRI has been loosely correlated with IDYA. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if GRI jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GRI
1D Price
Change %
GRI100%
-5.19%
IDYA - GRI
54%
Loosely correlated
+1.27%
SNSE - GRI
41%
Loosely correlated
-2.50%
NLSP - GRI
38%
Loosely correlated
+7.17%
GOVX - GRI
37%
Loosely correlated
+5.93%
INAB - GRI
36%
Loosely correlated
-0.92%
More

OCS and

Correlation & Price change

A.I.dvisor indicates that over the last year, OCS has been loosely correlated with SNSE. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if OCS jumps, then SNSE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCS
1D Price
Change %
OCS100%
+0.21%
SNSE - OCS
34%
Loosely correlated
-2.50%
CUE - OCS
33%
Poorly correlated
+9.14%
PRAX - OCS
29%
Poorly correlated
+1.64%
CGEN - OCS
28%
Poorly correlated
-3.55%
GRI - OCS
28%
Poorly correlated
-5.19%
More